Telehealth Platform Truemeds, closed its series B funding round at $22 million led by private equity fund Westbridge Capital. The new funding round also saw participation from existing investors including InfoEdge Ventures, Asha Impact and IAN Fund. The round witnessed oversubscription from new and existing investors.
The company plans to utilise the funds to accelerate growth in the untapped domestic market and expand its coverage across the country.
Founded by Ex-Abbott executives, Akshat Nayyar and Dr. Kunal Wani, Truemeds has witnessed phenomenal growth in the last 2 years on the back of strong product-market fit and a massive organic demand.
Commenting on the